Study Startup Has Enough Demands On Your Attention. RTSM Build Shouldn't Be One Of Them

By E.K. Koh, Chief Product Officer

Clinical trial startup is a race against time, and traditional RTSM builds often demand significant sponsor involvement during an already complex phase of study planning. Agentic RTSM is changing that dynamic by using AI-driven automation to streamline requirements, reducing kickoff-to-UAT timelines by up to 80% while maintaining the rigor required in regulated environments. This article explores how Suvoda's Agentic RTSM approach accelerates study builds without compromising compliance, quality, or auditability. Learn how AI agents and human expertise work together to simplify study setup, speed protocol amendments, and free sponsors to focus on higher-value startup activities such as site activation, regulatory readiness, and patient recruitment.